Europe Companion Animal Diagnostics Market

The Europe companion animal diagnostics market was valued at US$ 847.73 million in 2022 and is expected to reach US$ 1,710.14 million by 2030; it is estimated to register a CAGR of 9.2% from 2022 to 2030.

New Product Launches and Approvals Fuel Europe Companion Animal Diagnostics Market

Major companies in the animal diagnostics market are involved in research and development activities. In recent years, they have introduced several innovative and efficient products, and won regulatory approvals for the same, which has been creating ample opportunities in the market. In 2023, an industry leader in feline DNA testing and genetics, Basepaws, accelerated the landscape of health genetic testing by launching the most comprehensive DNA test for dogs into the canine market. The Basepaws Breed + Health Dog DNA Test facilitates the transition for pet owners from reactive to proactive care by providing a simple swabbing process and results that are optimized for mobile devices. In 2023, IDXX announced that the SNAP Leish 4Dx Test, a thorough screening tool for vector-borne illnesses such as canine leishmaniosis, will soon be available. In Europe, the test will be accessible from February 2024 onward. Under the CAG (Companion Animal Group) Diagnostics category, IDEXX offers diagnostic capabilities that satisfy the various demands of veterinarians. The company's latest advancement is proof of its dedication to growing its vector-borne disease portfolio, which will aid veterinarians throughout the globe in their endeavor to provide pets with higher-quality care.

Europe Companion Animal Diagnostics Market Overview

The European companion animal diagnostics market is divided into Germany, the UK, France, Italy, and Spain. The market growth across the region is attributed to factors such as the presence of various market players, rising research and development activities in the veterinary industry, growing numbers of diagnostics laboratories, and increasing number of pet adoptions.

The rapidly increasing pet adoption in Germany is fueling the market growth. According to the USDA Foreign Agricultural Service, more than 47% of German households have pets, and 15% of those households own more than one pet. The country saw a rapid increase in pet adoption during the COVID-19 lockdown period. Thus, the increasing pet adoption in the country will fuel the demand for diagnostics for care.

Also, the UK has various provisions for the care of companion animals, which propels the demand for animal disease diagnostics. The general anti-cruelty provisions under Section 4 of the Animal Welfare Act 2006, the Welfare of Animals Act (Northern Ireland) 2011, and Section 19 of the Animal Health and Welfare (Scotland) Act 2006 apply to companion animals. Section 9 of the Animal Welfare Act 2006 and the Welfare of Animals Act (Northern Ireland) 2011, and Section 24 of the Animal Health and Welfare (Scotland) Act 2006 also create a duty of care, i.e., a person adopting an animal is required to take reasonable steps (which includes the lawful purpose for which the animal is kept and any lawful activity undertaken in relation to the animal) to ensure the needs of the adopted animal are met to the extent required by good practice.

Europe Companion Animal Diagnostics Market Revenue and Forecast to 2030 (US$ Million)

Europe Companion Animal Diagnostics Market Segmentation

The Europe companion animal diagnostics market is segmented based on technique, product, application, companion animal type, end user, and country.

Based on technique, the Europe companion animal diagnostics market is segmented into immunodiagnostics, clinical biochemistry, molecular diagnostics, urinalysis, hematology, and others. The immunodiagnostics segment held the largest share in 2022. Immunodiagnostics segment is further categorized into lateral assays, ELISA tests, allergen-specific immunodiagnostics tests, and immunoassay analyzers. Clinical biochemistry segment is further categorized into clinical chemistry analysis, glucose monitoring, and blood gas electrolyte analysis. Also, biochemistry segment is categorized into PCR, microarray, and others.

By product, the Europe companion animal diagnostics market is bifurcated into instruments and consumables. The instruments segment held a larger share in 2022.

In terms of application, the Europe companion animal diagnostics market is categorized into bacteriology, clinical pathology, virology, parasitology, and others. The clinical pathology segment held the largest share in 2022.

Based on companion animal type, the Europe companion animal diagnostics market is segmented into dogs, cats, horses, and others. The dogs segment held the largest share in 2022.

By end user, the Europe companion animal diagnostics market is categorized into diagnostic laboratories, veterinary hospitals and clinics, research institutes, and others. The veterinary hospitals and clinics segment held the largest share in 2022.

Based on country, the Europe companion animal diagnostics market is categorized into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Germany dominated the Europe companion animal diagnostics market in 2022.

Demeditec Diagnostics GmbH, Heska Corp, Innovative Diagnostics SAS, i-SENS Inc, Immunology Consultants Laboratory Inc, Zoetis Inc, and Elabscience Biotechnology Inc are some of the leading companies operating in the Europe companion animal diagnostics market.